Working… Menu

SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03801889
Recruitment Status : Withdrawn (Protocol suspended prior to patient enrollment)
First Posted : January 14, 2019
Last Update Posted : October 5, 2020
Information provided by (Responsible Party):
Abfero Pharmaceuticals, Inc

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : January 2023